Renal dysfunction remains a global issue, with chronic kidney disease being the 18th most leading cause of death, worldwide. The increased demands in kidney transplants, led the scientific society to seek alternative strategies, utilizing mostly the tissue engineering approaches. Unlike to perfusion decellularization of kidneys, we proposed alternative decellularization strategies to obtain acellular kidney scaffolds. The aim of this study was the evaluation of two different decellularization approaches for producing kidney bioscaffolds.
Rat kidneys from Wistar rats, were submitted to decellularization, followed two different strategies. The decellularization solutions used in both approaches were the same and involved the use of 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate and sodium dodecyl sulfate buffers for 12 h each, followed by incubation in a serum medium. Both approaches involved 3 decellularization cycles. Histological analysis, biochemical and DNA quantification were performed. Cytotoxicity assay and repopulation of acellular kidneys were also applied.
Histological, biochemical and DNA quantification confirmed that the 2nd approach had the best outcome regarding the kidney composition and cell elimination. Acellular kidneys from both approaches were successfully recellularized.
Based on the above data, the production of kidney scaffolds with the proposed cost- effective decellularization approaches, was efficient.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020;16:251.
Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389:1238–52.
Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, et al. Nomenclature for kidney function and disease: report of a kidney disease: improving global outcomes (KDIGO) consensus conference. Kidney Int. 2020;97:1117–29.
Goldfarb-Rumyantzev AS, Rout P. Characteristics of elderly patients with diabetes and end-stage renal disease. Semin Dial. 2010;23:185–90.
London GM. Arterial stiffness in chronic kidney disease and end-stage renal disease. Blood Purif. 2018;45:154–8.
Kaysen GA, Eiserich JP. Characteristics and effects of inflammation in end-stage renal disease. Semin Dial. 2003;16:438–46.
Lu Y, Stamm C, Nobre D, Pruijm M, Teta D, Cherpillod A, et al. Changing trends in end-stage renal disease patients with diabetes. Swiss Med Wkly. 2017;147:w14458.
Jiang Y, Fine JP, Mottl AK. Competing risk of death with end-stage renal disease in diabetic kidney disease. Adv Chronic Kidney Dis. 2018;25:133–40.
Jha V, Modi GK. Getting to know the enemy better-the global burden of chronic kidney disease. Kidney Int. 2018;94:462–4.
Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–81.
Bowe B, Xie Y, Li T, Mokdad AH, Xian H, Yan Y, et al. Changes in the US Burden of chronic kidney disease from 2002 to 2016: an analysis of the global burden of disease study. JAMA Netw Open. 2018;1:e184412.
Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96:414-422D.
Lobbedez T, Lecouf A, Abbadie O, Ficheux M, de Ligny BH, Ryckelynck JP. Peritoneal dialysis and renal transplantation. Contrib Nephrol. 2009;163:250–6.
Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int. 2002;62:1423–30.
Molnar MZ, Mehrotra R, Duong U, Bunnapradist S, Lukowsky LR, Krishnan M, et al. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7:332–41.
Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D. Medical costs of CKD in the Medicare population. J Am Soc Nephrol. 2013;24:1478–83.
Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16:573–85.
De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies–an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999;14 Suppl 6:31–41.
Yang F, Lau T, Luo N. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Nephrology (Carlton). 2016;21:669–77.
Fu R, Sekercioglu N, Berta W, Coyte PC. Cost-effectiveness of deceased-donor renal transplant versus dialysis to treat end-stage renal disease: a systematic review. Transplant Direct. 2020;6:e522.
Heldal K, Midtvedt K, Lønning K, Iversen T, Hernæs KH, Tsarpali V, et al. Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost-utility study. Clin Kidney J. 2019;12:888–94.
Augustine J. Kidney transplant: new opportunities and challenges. Cleve Clin J Med. 2018;85:138–44.
Hernández D, Alonso-Titos J, Armas-Padrón AM, Lopez V, Cabello M, Sola E, et al. Waiting list and kidney transplant vascular risk: an ongoing unmet concern. Kidney Blood Press Res. 2020;45:1–27.
Veroux M, Corona D, Veroux P. Kidney transplantation: future challenges. Minerva Chir. 2009;64:75–100.
National kidney Foundation. Organ Donation and Transplantation Statistics. https://www.kidney.org/news/newsroom/factsheets/Organ-Donation-and-Transplantation-Stats. 2020.
Tapias LF, Ott HC. Decellularized scaffolds as a platform for bioengineered organs. Curr Opin Organ Transplant. 2014;19:145–52.
Ozbolat IT, Yu Y. Bioprinting toward organ fabrication: challenges and future trends. IEEE Trans Biomed Eng. 2013;60:691–9.
Zhang X, Zhang Y. Tissue engineering applications of three-dimensional bioprinting. Cell Biochem Biophys. 2015;72:777–82.
Ali M, PR AK, Lee SJ, Jackson JD. Three-dimensional bioprinting for organ bioengineering: promise and pitfalls. Curr Opin Organ Transplant. 2018;23:649–656.
Kačarević ŽP, Rider PM, Alkildani S, Retnasingh S, Smeets R, Jung O, et al. An introduction to 3D bioprinting: possibilities, challenges and future aspects. Materials (Basel). 2018;11:2199.
Bishop ES, Mostafa S, Pakvasa M, Luu HH, Lee MJ, Wolf JM, et al. 3-D bioprinting technologies in tissue engineering and regenerative medicine: current and future trends. Genes Dis. 2017;4:185–95.
Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials. 2006;27:3675–83.
Gilbert TW. Strategies for tissue and organ decellularization. J Cell Biochem. 2012;113:2217–22.
Wallace MA. Anatomy and physiology of the kidney. AORN J. 1998;68:819–20.
Glassock RJ, Rule AD. Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease. Nephron. 2016;134:25–9.
Figliuzzi M, Bonandrini B, Remuzzi A. Decellularized kidney matrix as functional material for whole organ tissue engineering. J Appl Biomater Funct Mater. 2017;15:e326–33.
Abolbashari M, Agcaoili SM, Lee MK, Ko IK, Aboushwareb T, Jackson JD, et al. Repopulation of porcine kidney scaffold using porcine primary renal cells. Acta Biomater. 2016;29:52–61.
Guan Y, Liu S, Liu Y, Sun C, Cheng G, Luan Y, et al. Porcine kidneys as a source of ECM scaffold for kidney regeneration. Mater Sci Eng C Mater Biol Appl. 2015;56:451–6.
Sullivan DC, Mirmalek-Sani SH, Deegan DB, Baptista PM, Aboushwareb T, Atala A, et al. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials. 2012;33:7756–64.
Wang Y, Bao J, Wu Q, Zhou Y, Li Y, Wu X, et al. Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts. Xenotransplantation. 2015;22:48–61.
Liu RF, Gao JS, Yang YF, Zeng WX. Preparation of rat whole-kidney acellular matrix via peristaltic pump. Urol J. 2015;12:2457–61.
Kajbafzadeh AM, Khorramirouz R, Nabavizadeh B, Ladi Seyedian SS, Akbarzadeh A, Heidari R, et al. Whole organ sheep kidney tissue engineering and in vivo transplantation: Effects of perfusion-based decellularization on vascular integrity. Mater Sci Eng C Mater Biol Appl. 2019;98:392–400.
Destefani AC, Sirtoli GM, Nogueira BV. Advances in the Knowledge about Kidney Decellularization and Repopulation. Front Bioeng Biotechnol. 2017;1:34.
Chani B, Puri V, Sobti RC, Jha V, Puri S. Decellularized scaffold of cryopreserved rat kidney retains its recellularization potential. PLoS One. 2017;7:e0173040.
Katsimpoulas M, Morticelli L, Gontika I, Kouvaka A, Mallis P, Dipresa D, et al. Biocompatibility and immunogenicity of decellularized allogeneic aorta in the orthotopic rat model. Tissue Eng Part A. 2019;25:399–415.
Mallis P, Gontika I, Poulogiannopoulos T, Zoidakis J, Vlahou A, Michalopoulos E, et al. Evaluation of decellularization in umbilical cord artery. Transplant Proc. 2014;46:3232–9.
Dimou Z, Michalopoulos E, Katsimpoulas M, Dimitroulis D, Kouraklis G, Stavropoulos-Giokas C, et al. Evaluation of a decellularization protocol for the development of a decellularized tracheal scaffold. Anticancer Res. 2019;39:145–50.
Mallis P, Chachlaki P, Katsimpoulas M, Stavropoulos-Giokas C, Michalopoulos E. Optimization of decellularization procedure in rat esophagus for possible development of a tissue engineered construct. Bioengineering (Basel). 2018;6:3.
Mallis P, Papapanagiotou A, Katsimpoulas M, Kostakis A, Siasos G, Kassi E, et al. Efficient differentiation of vascular smooth muscle cells from Wharton’s Jelly mesenchymal stromal cells using human platelet lysate: A potential cell source for small blood vessel engineering. World J Stem Cells. 2020;12:203–21.
Rustad KC, Sorkin M, Levi B, Longaker MT, Gurtner GC. Strategies for organ level tissue engineering. Organogenesis. 2010;6:151–7.
Welman T, Michel S, Segaren N, Shanmugarajah K. Bioengineering for organ transplantation: progress and challenges. Bioengineered. 2015;6:257–61.
Arenas-Herrera JE, Ko IK, Atala A, Yoo JJ. Decellularization for whole organ bioengineering. Biomed Mater. 2013;8:014106.
Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3:471–80.
Linden EA, Cano J, Coritsidis GN. Kidney transplantation in undocumented immigrants with ESRD: a policy whose time has come? Am J Kidney Dis. 2012;60:354–9.
Husain SA, King KL, Pastan S, Patzer RE, Cohen DJ, Radhakrishnan J, et al. Association between declined offers of deceased donor kidney allograft and outcomes in kidney transplant candidates. JAMA Netw Open. 2019;2:e1910312.
Wainright JL, Klassen DK, Kucheryavaya AY, Stewart DE. Delays in prior living kidney donors receiving priority on the transplant waiting list. Clin J Am Soc Nephrol. 2016;11:2047–52.
Madariaga ML, Ott HC. Bioengineering kidneys for transplantation. Semin Nephrol. 2014;34:384–93.
Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, et al. Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Expert Rev Clin Immunol. 2016;12:169–82.
Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, et al. Prospect for kidney bioengineering: shortcomings of the status quo. Expert Opin Biol Ther. 2015;15:547–58.
Lin YQ, Wang LR, Pan LL, Wang H, Zhu GQ, Liu WY, et al. Kidney bioengineering in regenerative medicine: An emerging therapy for kidney disease. Cytotherapy. 2016;18:186–97.
Vijayavenkataraman S, Yan WC, Lu WF, Wang CH, Fuh JYH. 3D bioprinting of tissues and organs for regenerative medicine. Adv Drug Deliv Rev. 2018;132:296–332.
Mandrycky C, Wang Z, Kim K, Kim DH. 3D bioprinting for engineering complex tissues. Biotechnol Adv. 2016;34:422–34.
Bonandrini B, Figliuzzi M, Papadimou E, Morigi M, Perico N, Casiraghi F, et al. Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells. Tissue Eng Part A. 2014;20:1486–98.
Leuning DG, Witjas FMR, Maanaoui M, de Graaf AMA, Lievers E, Geuens T, et al. Vascular bioengineering of scaffolds derived from human discarded transplant kidneys using human pluripotent stem cell-derived endothelium. Am J Transplant. 2019;19:1328–43.
Fedecostante M, Onciu OG, Westphal KGC, Masereeuw R. Towards a bioengineered kidney: recellularization strategies for decellularized native kidney scaffolds. Int J Artif Organs. 2017;9:150–8.
Caralt M, Uzarski JS, Iacob S, Obergfell KP, Berg N, Bijonowski BM, et al. Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant. 2015;15:64–75.
Mallis P, Sokolis DP, Makridakis M, Zoidakis J, Velentzas AD, Katsimpoulas M, et al. Insights into biomechanical and proteomic characteristics of small diameter vascular grafts utilizing the human umbilical artery. Biomedicines. 2020;8:280.
Hwang J, San BH, Turner NJ, White LJ, Faulk DM, Badylak SF, et al. Molecular assessment of collagen denaturation in decellularized tissues using a collagen hybridizing peptide. Acta Biomater. 2017;53:268–78.
Mallis P, Katsimpoulas M, Kostakis A, Dipresa D, Korossis S, Papapanagiotou A, et al. Vitrified human umbilical arteries as potential grafts for vascular tissue engineering. Tissue Eng Regen Med. 2020;17:285–99.
Zhang Z, Wu W, Fang X, Lu M, Wu H, Gao C, et al. Sox9 promotes renal tubular epithelial-mesenchymal transition and extracellular matrix aggregation via the PI3K/AKT signaling pathway. Mol Med Rep. 2020;22:4017–30.
White LR, Blanchette JB, Ren L, Awn A, Trpkov K, Muruve DA. The characterization of alpha5-integrin expression on tubular epithelium during renal injury. Am J Physiol Renal Physiol. 2007;292:F567–76.
Khamchun S, Sueksakit K, Chaiyarit S, Thongboonkerd V. Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix. J Biol Inorg Chem. 2019;24:235–46.
Van Vliet A, Baelde HJ, Vleming LJ, de Heer E, Bruijn JA. Distribution of fibronectin isoforms in human renal disease. J Pathol. 2001;193:256–62.
Luo J, Korossis SA, Wilshaw SP, Jennings LM, Fisher J, Ingham E. Development and characterization of acellular porcine pulmonary valve scaffolds for tissue engineering. Tissue Eng Part A. 2014;20:2963–74.
Gontika I, Katsimpoulas M, Antoniou E, Kostakis A, Stavropoulos-Giokas C, Michalopoulos E. Decellularized human umbilical artery used as nerve conduit. Bioengineering (Basel). 2018;5:100.
Jafari M, Mehrnejad F, Rahimi F, Asghari SM. The molecular basis of the sodium dodecyl sulfate effect on human ubiquitin structure: a molecular dynamics simulation study. Sci Rep. 2018;8:2150.
Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44:215–30.
Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–36.
Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106:984–91.
Machado Cde V, Telles PD, Nascimento IL. Immunological characteristics of mesenchymal stem cells. Rev Bras Hematol Hemoter. 2013;35:62–7.
Remuzzi A, Figliuzzi M, Bonandrini B, Silvani S, Azzollini N, Nossa R, et al. Experimental evaluation of kidney regeneration by organ scaffold recellularization. Sci Rep. 2017;7:43502.
Ross EA, Abrahamson DR, St John P, Clapp WL, Williams MJ, Terada N, et al. Mouse stem cells seeded into decellularized rat kidney scaffolds endothelialize and remodel basement membranes. Organogenesis. 2012;8:49–55.
Fu RH, Wang YC, Liu SP, Shih TR, Lin HL, Chen YM, et al. Decellularization and recellularization technologies in tissue engineering. Cell Transplant. 2014;23:621–30.
Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng. 2011;13:27–53.
O’Brien FJ, Harley BA, Waller MA, Yannas IV, Gibson LJ, Prendergast PJ. The effect of pore size on permeability and cell attachment in collagen scaffolds for tissue engineering. Technol Health Care. 2007;15:3–17.
O’Brien FJ, Harley BA, Yannas IV, Gibson LJ. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials. 2005;26:433–41.
Vissers CAB, Harvestine JN, Leach JK. Pore size regulates mesenchymal stem cell response to Bioglass-loaded composite scaffolds. J Mater Chem B. 2015;3:8650–8.
Hussein KH, Saleh T, Ahmed E, Kwak HH, Park KM, Yang SR, et al. Biocompatibility and hemocompatibility of efficiently decellularized whole porcine kidney for tissue engineering. J Biomed Mater Res A. 2018;106:2034–47.
Kobayashi T, Cooper DK. Anti-Gal, alpha-Gal epitopes, and xenotransplantation. Subcell Biochem. 1999;32:229–57.
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–33.
Yin L, Du G, Zhang B, Zhang H, Yin R, Zhang W, et al. Efficient drug screening and nephrotoxicity assessment on co-culture microfluidic kidney chip. Sci Rep. 2020;10:6568.
Fedecostante M, Westphal KGC, Buono MF, Sanchez Romero N, Wilmer MJ, Kerkering J, et al. Recellularized native kidney scaffolds as a novel tool in nephrotoxicity screening. Drug Metab Dispos. 2018;46:1338–50.
Conflict of interest
The authors declare no conflict of interest for this study.
The study protocol involved the harvest of kidneys from Wistar Rats, weighing 300–350 gr. All care and handling of the animals were provided according to the Guide for the Care and Use of Laboratory Animals of BRFAA, conformed to the Directive 2010/63/EU of the European Parliament, and has been approved by the Bioethics Committee of BRFAA (ref 25–2019). The WJ-MSCs used in the current research study were provided by the Hellenic Cord Blood Bank (HCBB) located at the Biomedical Research Foundation Academy of Athens (BRFAA). All human umbilical cords, used for the WJ-MSCs, were accompanied by informed consent and signed by the mothers before the delivery. In addition all human umbilical cords were derived from male donors. Also, the informed consent was in accordance with the ethical standards of the Greek National Ethical Committee and has been accepted by the Institution’s ethical board (Ref 2578/32).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Mallis, P., Oikonomidis, C., Dimou, Z. et al. Optimizing Decellularization Strategies for the Efficient Production of Whole Rat Kidney Scaffolds. Tissue Eng Regen Med (2021). https://doi.org/10.1007/s13770-021-00339-y
- Kidney scaffold
- Chronic kidney disease
- Mesenchymal stromal cells
- Static seeding